MIRA INFORM REPORT

 

 

Report Date :

13.08.2013

 

IDENTIFICATION DETAILS

 

Name :

MS PHARMA

 

 

Formerly Known As :

NINEVEH DRUG INDUSTRY (NDI)

 

 

Registered Office :

Zahran Plaza Building, 2nd Floor Zahran Street 7th Circle PO Box    142904 Amman 11844

 

 

Country :

Jordan

 

 

Date of Incorporation :

22.06.2013

 

 

Com. Reg. No.:

2576, Amman

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacturers of pharmaceuticals

 

 

No. of Employees :

25

 

RATING & COMMENTS

 

MIRA’s Rating :

NB

 

RATING

STATUS

PROPOSED CREDIT LINE

--

NB

New Business

 

--

 

Status :

New Business

Payment Behaviour :

Unknown

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Jordan

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

JORDAN - ECONOMIC OVERVIEW

 

Jordan's economy is among the smallest in the Middle East, with insufficient supplies of water, oil, and other natural resources, underlying the government's heavy reliance on foreign assistance. Other economic challenges for the government include chronic high rates of poverty, unemployment, inflation, and a large budget deficit. Since assuming the throne in 1999, King ABDALLAH has implemented significant economic reforms, such as opening the trade regime, privatizing state-owned companies, and eliminating some fuel subsidies, which in the last decade spurred economic growth by attracting foreign investment and creating some jobs. The global economic slowdown and regional turmoil, however, have depressed Jordan''s GDP growth, impacting export-oriented sectors, construction, and tourism. In 2011 and 2012, the government approved two economic relief packages and a budgetary supplement, meant to improve the living conditions for the middle and poor classes. Jordan''s finances have also been strained by a series of natural gas pipeline attacks in Egypt, causing Jordan to substitute more expensive diesel imports, primarily from Saudi Arabia, to generate electricity. Jordan is currently exploring nuclear power generation in addition to the exploitation of abundant oil shale reserves and renewable technologies to forestall energy shortfalls. In 2012, to correct budgetary and balance of payments imbalances, Jordan entered into a $2.1 billion, multiple year International Monetary Fund Stand-By Arrangement. Jordan''s financial sector has been relatively isolated from the international financial crisis because of its limited exposure to overseas capital markets. Jordan will continue to depend heavily on foreign assistance to finance the deficit in 2013.

Source : CIA

 

SUMMARY

 

Company Name                                     : MS PHARMA

Also Known As                                      : NINEVEH DRUG INDUSTRY (NDI)

Country of Origin                                    : Jordan

Legal Form                                            : Limited Liability Company

Registration Date                                   : 22nd June 2013

Commercial Registration Number            : 2576, Amman

Issued Capital                                        : JD 50,000

Paid up Capital                                      : JD 50,000

Total Workforce                                     : 25

Activities                                               : Manufacturers of pharmaceuticals

Financial Condition                                 : Undetermined

Payments                                             : Nothing detrimental uncovered

 

 

 


COMPANY NAMe

 

MS PHARMA

 

ALSO KNOWN AS: NINEVEH DRUG INDUSTRY (NDI)

 

 

ADDRESS

 

Registered & Physical Address

 

Building             : Zahran Plaza Building, 2nd Floor

Street               : Zahran Street

Area                 : 7th Circle

 

PO Box             : 142904

 

Town                 : Amman 11844

Country             : Jordan

 

Telephone         : (962-6) 5827999

Facsimile          : (962-6) 5820876

Email                : saleh.aburashed@mspharma.com

 

Premises

 

Subject operates from a small suite of offices that are rented and located in the Central Business Area of Amman.

 

 

KEY PRINCIPALS

 

     Name                                                                                                           Position

 

·       Gayas Mounir Soukhtian                                                                                Managing Director

 

·       Saleh Abu Rashed                                                                                        Quality Manager

 

·       Ayman Ibrahim                                                                                              Operations Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 22nd June 2013

 

Legal Form                  : Limited Liability Company

 

Commercial Reg. No.  : 2576, Amman

 

Issued Capital              : JD 50,000

 

Paid up Capital            : JD 50,000

 

Name of Shareholder (s)

 

·       Gayas Mounir Soukhtian

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of pharmaceuticals in third parties facilities in Iraq.

 

Subject has a workforce of 25 employees.

 

 

FINANCIAL DATA

 

Subject is a newly formed business and as a result financial information is not currently available.

 

 

BANKERS

 

·       Bank of Jordan Ltd

Jebel Amman

PO Box: 2140

Amman

Tel: (962-6) 642034

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

In view of subject’s infancy, extensive payment and financial are not available, therefore dealings are recommended to be on secured terms, and a close monitoring of subject’s business development is advisable.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.80

UK Pound

1

Rs.94.21

Euro

1

Rs.81.03

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.